CLINICAL_TRIALS
ClinicalTrials.gov record update
Optical Coherence Tomography Angiography (AngioVue™, Optovue Inc., Fremont, Calif., USA) Characteristics of Patients With Surgically Closed Full-thickness Idiopathic Macular Holes < 600 μm With Air Versus 10% SF6 Tamponade - a Pilot Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05223205
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:35.454426+00:00
- Published At
- 2023-09-13T00:00:00+00:00
- Record Updated At
- 2023-09-13
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Macular Holes", "Optical Coherence Tomography"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-09-13"- protocolSection.identificationModule.nctId
"NCT05223205"- protocolSection.identificationModule.officialTitle
"Optical Coherence Tomography Angiography (AngioVue\u2122, Optovue Inc., Fremont, Calif., USA) Characteristics of Patients With Surgically Closed Full-thickness Idiopathic Macular Holes \u003c 600 \u03bcm With Air Versus 10% SF6 Tamponade - a Pilot Study"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["NA"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.